Acquisition Completed

Incyte acquisition of Vega Therapeutics

US$1.3bn consideration

Announced 8 Jun 2026

Advisers

Vega Therapeutics

Target

Financial adviser
Legal adviser

Incyte

Acquirer

Financial adviser
Legal adviser

Other advisers

Financial adviser
Target
Vega Therapeutics
Acquirer
Incyte
Seller
Star Therapeutics
Target based in
United States
Buyer based in
United States
Seller based in
United States
Completed
6 Jul 2026
Sector
Biotech
Tags
Biotech, Drug Development, Rare Disease

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.